Save this content for laterSave this content on your device for later, even while offline Sign in with FacebookSign in with your Facebook account Close

Spectranetics set for largest acquisition in company history

By: WAYNE HEILMAN wayneh@gazette.com
May 27, 2014 Updated: May 27, 2014 at 4:32 pm
0
Caption +
Spectranetics CEO Scott Drake poses in this 2011 file photo. The company is poised to purchase AngioScore Inc., in what will be Spectranetics' largest acquisition ever. (The Gazette, Christian Murdock)

Spectranetics Corp. announced Tuesday the Colorado Springs-based medical laser manufacturer will next month acquire a California company that manufactures angioplasty balloons in a $230 million deal that is the biggest acquisition in its 30-year history.

Spectranetics will acquire Fremont, Calif.-based AngioScore Inc., a privately held firm that develops, manufactures and sells cardiovascular specialty balloons, in a deal evenly split between cash and stock, though the company said it plans to finance the entire purchase price by issuing $200 million Wednesday in 20-year bonds that could be converted into stock. The transaction is expected to be completed by June 30, when AngioScore will become a subsidiary of Spectranetics.

"The attractiveness of this deal compelled us to act," Spectranetics CEO Scott Drake said in a conference call Tuesday with stock analysts, investors and others. "This combination makes perfect sense in terms of strategic fit, technology, scale and reach."

AngioScore was started in 2003 by a California cardiologist and a veteran of the medical device industry and generated $55 million in revenue last year, growing at an annual rate of 14 percent during the past three years and 20 percent last year. The company employs 170.

The combined company had revenue totaling $213.5 million and generated operating earnings of $10.1 million. Spectranetics said in a press release announcing the deal that it expects the acquisition to add to operating earnings next year and save up to $10 million in annual operating costs.

"Simply put, we are 'better together,'" AngioScore CEO Thomas Trotter said the release. "We believe that this combination provides an opprotunity to build a remarkable future while delivering life-impacting technologies to physicians and patients."

Register to the Colorado Springs Gazette
Incognito Mode Your browser is in Incognito mode

You vanished!

We welcome you to read all of our stories by signing into your account. If you don't have a subscription, please subscribe today for daily award winning journalism.

Register to the Colorado Springs Gazette
Register to the Colorado Springs Gazette
Subscribe to the Colorado Springs Gazette

It appears that you value local journalism. Thank you.

Subscribe today for unlimited digital access with 50% fewer ads for a faster browsing experience.

Already a Subscriber? LOGIN HERE

Subscribe to the Colorado Springs Gazette

It appears that you value local journalism. Thank you.

Subscribe today for unlimited digital access with 50% fewer ads for a faster browsing experience.

Subscribe to the Colorado Springs Gazette

Some news is free.
Exceptional journalism takes time, effort and your support.

Already a Subscriber? LOGIN HERE

articles remaining
×
Thank you for your interest in local journalism.
Gain unlimited access, 50% fewer ads and a faster browsing experience.